GlassScriptPhysician profile
Meghan Stuver Wright
NPI 1932540838
$3,386.76
in general payments reported to CMS, 2019-2025
28 companies · $886 in 2025
The $886 reported for 2025 was more than what 78% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $324 · 2022: $744 · 2023: $691 · 2024: $742 · 2025: $886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,319.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $518.38 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan, Linq II |
| Boston Scientific Corporation | $410.36 | 2022-2025 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd, Watchman |
| E.R. Squibb & Sons, L.L.C. | $401.35 | 2021-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $313.47 | 2021-2025 | Jardiance |
| Pfizer INC. | $275.35 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $182.15 | 2021-2023 | Xarelto |
| Biosense Webster, INC. | $173.57 | 2023-2025 | Carto 3, Octaray Mapping Catheter |
| Kiniksa Pharmaceuticals International, Plc | $146.58 | 2024 | Arcalyst |
| Abbott Laboratories | $133.81 | 2022-2025 | Perclose Prostyle, Gallant |
| Amgen INC. | $116.35 | 2022-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $114.15 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $90.20 | 2022-2025 | Farxiga, Wainua |
| Kestra Medical Technology Services, INC. | $74.50 | 2023 | Assure Wcd |
| Biotronik INC. | $55.23 | 2021-2022 | |
| Abiomed | $50.32 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $46.23 | 2023-2024 | Rybelsus, Ozempic |
| Atricure, INC. | $34.83 | 2024 | |
| Inari Medical, INC. | $33.78 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cvrx, INC. | $30.67 | 2023 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.50 | 2021-2022 | |
| Irhythm Technologies, INC. | $26.22 | 2024 | Zio Xt Patch, Zio Monitor |
| Sanofi-Aventis U.S. LLC | $25.58 | 2024 | |
| Edwards Lifesciences Corporation | $20.00 | 2023 | Sapien 3 Ultra Resilia |
| Bridgebio Pharma, INC. | $19.97 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $18.24 | 2023 | Verquvo |
| Chiesi USA, INC. | $15.99 | 2025 | Cleviprex, Kengreal |
| Alnylam Pharmaceuticals INC. | $15.85 | 2025 | Amvuttra |
| Lexicon Pharmaceuticals, INC. | $13.13 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.